Hypoattenuated Leaflet Thickening: A Comprehensive Review of Contemporary Data

Nika Samadzadeh Tabrizi1, Gregory Fishberger2, Sridhar R Musuku1

  • 1Department of Anesthesiology, Albany Medical Center, Albany, NY.

Insights

Hypoattenuated leaflet thickening (HALT) affects nearly one-third of patients after aortic valve replacement. This review examines HALT risk factors, prevention, and treatment for better patient outcomes.

Area of Science:

  • Cardiology
  • Cardiac Surgery
  • Radiology

Background:

  • Hypoattenuated leaflet thickening (HALT) is common after surgical aortic valve replacement (SAVR) and transcatheter aortic valve replacement (TAVR).
  • HALT often indicates subclinical leaflet thrombosis but can progress to valve dysfunction.
  • There is no current consensus on HALT screening or management.

Purpose of the Study:

  • To comprehensively review the evidence on risk factors, prevention, treatment, and prognosis of HALT.
  • To address the clinical significance and management of HALT in patients post-SAVR and TAVR.

Main Methods:

  • Systematic review of existing literature on HALT.
  • Evaluation of studies reporting on risk factors, clinical presentation, and outcomes of HALT.
  • Analysis of current screening and management strategies.

Main Results:

  • HALT affects approximately one-third of patients within one year of SAVR or TAVR.
  • HALT is often incidentally detected in asymptomatic patients.
  • Progression of HALT can lead to leaflet immobility and valve deterioration.

Conclusions:

  • Further research is needed to clarify the clinical significance of HALT.
  • Establishing standardized screening and management protocols for HALT is crucial.
  • Understanding HALT is essential for optimizing long-term outcomes after aortic valve replacement.

Related Concept Videos

Mitral Valve Prolapse I: Introduction01:27

Mitral Valve Prolapse I: Introduction

IntroductionThe mitral valve, one of the heart's four valves, regulates blood flow. These valves have flaps that open and close to direct blood properly through the heart and body. During each heartbeat, the flaps open for blood to pass through and seal shut to prevent backflow. Specifically, the mitral valve opens to allow blood flow from the heart's upper left chamber to the lower left chamber. It then closes securely as the lower left chamber contracts to pump blood to the body, preventing...
Mitral Valve Prolapse II: Assessment and Management01:22

Mitral Valve Prolapse II: Assessment and Management

IntroductionA range of clinical features characterizes Mitral Valve Prolapse (MVP), but it is important to note that many individuals with MVP are asymptomatic and may remain so throughout their lives. For those who do exhibit symptoms, the following are the key clinical features:Palpitations: This is a common symptom where individuals feel an irregular or rapid heartbeat. Palpitations in MVP are often due to arrhythmias such as premature ventricular contractions or supraventricular tachycardia.
Mitral Regurgitation I: Introduction01:20

Mitral Regurgitation I: Introduction

Mitral regurgitation is characterized by the backward circulation of blood from the left ventricle to the left atrium during systole, a phase of the cardiac cycle when the heart contracts and pumps blood out of the chambers. This abnormal flow occurs primarily due to the dysfunction of the mitral valve or its supporting structures, which include the mitral leaflets, chordae tendineae, annulus, and papillary muscles.Etiology and Mechanisms:Primary Mitral Regurgitation: This type arises from...
Mitral Regurgitation III: Medical Management01:25

Mitral Regurgitation III: Medical Management

Mitral regurgitation (MR) is characterized by retrograde blood circulation from the left ventricle into the left atrium due to inadequate mitral valve closure. The severity of the condition, symptoms, and underlying cause determine treatment strategies.Monitoring and Pharmacological TreatmentPatients with mild to moderate MR typically do not need immediate intervention but regular monitoring to assess progression and guide treatment. Patients with mild MR should have an echocardiogram every 3-5...
Aortic Regurgitation I: Introduction01:15

Aortic Regurgitation I: Introduction

IntroductionAortic regurgitation is characterized by the backward flow of blood from the aorta into the left ventricle during diastole and arises from the improper closure of the aortic valve. This condition results in left ventricular volume overload and can stem from both acute and chronic etiologies, each contributing uniquely to the disease's progression and symptomatology.Acute and Chronic CausesAcute aortic regurgitation often results from events that suddenly impair the integrity of the...
Acute Coronary Syndrome III: Diagnostic Studies01:30

Acute Coronary Syndrome III: Diagnostic Studies

Diagnosing acute coronary syndrome or ACS begins with a thorough patient history. Notable symptoms include central, crushing chest pain radiating to the left arm, neck, jaw, or back, along with shortness of breath, sweating (diaphoresis), nausea, vomiting, dizziness, and palpitations.It is crucial to note any history of cardiac illnesses and assess risk factors, including age, gender, smoking, hypertension, diabetes, hyperlipidemia, and a sedentary lifestyle.During physical examination, vital...